510(k) Report

510(k) · Cleared

Cleared

Myolight

K033874510(k) TraditionalCleared Dec 30, 200315-day reviewClass II21 CFR 892.1200

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Ge Medical Systems F.I. Haifa · KPS System, Tomography, Computed, Emission

Cleared on Dec 30, 2003 as substantially equivalent to K021823 (Nuclear Cardiology Systems, Inc., 2002) after a 15-day review. Its family tree reaches back 2 generations to 2002. 1 later device descends from it.

Decided
Dec 30, 2003
Review
15 days
Class
Class II
Product code
KPS
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K013353 (2002). 1 later device descends from it, 1 citing it directly.

Descendants, by generation 1 generation forward: 1 descendant K021823 · Cardiospect D90/Cardio Cam · Nuclear Cardiology Systems, Inc. · 2002K013353 · Neurospectquad Gamma Camera · Nuclear Cardiology Systems, Inc. · 20020
  1. Root · 2 generations backK013353 Neurospectquad Gamma CameraNuclear Cardiology Systems, Inc. · 2002
  2. 1 generation backK021823 Cardiospect D90/Cardio CamNuclear Cardiology Systems, Inc. · 2002
  3. This deviceK033874 MyolightGe Medical Systems F.I. Haifa · 2003
  4. Descendant · cites it directly · 0 of its ownK070589 C!Transphoton Corporation · 2007

Most influential descendants

Showing 1 of 1 · See all
  • K070589C!Transphoton Corporation · 2007 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K013353Neurospectquad Gamma CameraNuclear Cardiology Systems, Inc.2002—
−1K021823Cardiospect D90/Cardio CamNuclear Cardiology Systems, Inc.2002—
0 (this device)K033874MyolightGe Medical Systems F.I. Haifa2003—
+1K070589C!Transphoton Corporation2007—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200710
FIG. 1 — Lineage of K033874, 2002–2007Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KPS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KPS device

  1. #1 K253564 uMI Panvivo (uMI Panvivo); uMI Panvivo (uMI…score 18.7 · 17 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K021823Cardiospect D90/Cardio Cam
Summary page 1
…Modification of legally marketed device. Identification of Legally Marketed Equivalent Devices Nuclear Cardiology System: CARDIOSPECT D90 - K021823 (Manufactured by MEDISO Budapest) MyoLight 510k draft DEC_08_2003.doc…
Nuclear Cardiology Systems, Inc.2002—

Also cleared against K021823: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K070589C!Transphoton Corporation20070

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 1 year and passes through 2 companies; a new generation was cleared every 1.5 years on median.
  • None of the 2 ancestors has a recall.
  • Of its descendants, K070589 (Transphoton Corporation, 2007) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K021823.

How does its category compare?

All KPS devices

KPS System, Tomography, Computed, Emission: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · KPS

12in 2025

2007: 82008: 172009: 92010: 32011: 72012: 62013: 112014: 112015: 32016: 112017: 112018: 132019: 32020: 122021: 152022: 52023: 122024: 112025: 122026 (partial year): 6
2007high 17 (2008) · low 3 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KPS

65in 2025

2007: 38 days median2008: 25 days median2009: 42 days median2010: 91 days median2011: 28 days median2012: 94 days median2013: 84 days median2014: 92 days median2015: 112 days median2016: 65 days median2017: 104 days median2018: 59 days median2019: 60 days median2020: 72 days median2021: 66 days median2022: 60 days median2023: 63 days median2024: 59 days median2025: 65 days median2026 (partial year): 67 days median
2007high 112 (2015) · low 25 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KPS

16in 2025

2007: 222008: 162009: 142010: 42011: 342012: 132013: 132014: 182015: 52016: 162017: 112018: 12, 3 Class I2019: 5, 5 Class I2020: 82021: 42022: 8, 6 Class I2023: 6, 3 Class I2024: 152025: 162026 (partial year): 6
2007high 34 (2011) · low 4 (2010)2026

Class I (17 since 2007) Class II/III not classified

Adverse event reports per year · KPS

36in 2025

2007: 382008: 112009: 152010: 442011: 562012: 342013: 2402014: 332015: 242016: 102017: 312018: 262019: 1052020: 222021: 102022: 152023: 222024: 232025: 36
2007high 240 (2013) · low 10 (2016)2025

MAUDE reports naming product code KPS, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20078382238
200817251611
20099421415
2010391444
20117283456
20126941334
2013118413240
201411921833
20153112524
201611651610
2017111041131
2018135912 (3)26
20193605 (5)105
20201272822
20211566410
20225608 (6)15
202312636 (3)22
202411591523
202512651636
20266676—

What is it indicated for?

The intended use of the MyoLIGHT system is to perform Nuclear imaging procedures for detection and imaging of single photon radioisotope tracer uptake in the patient body for clinical diagnostic purposes.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K033874: Myolight.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K033874

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026